Nykredit A S acquired a new position in Centene Corporation (NYSE:CNC – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 134,334 shares of the company’s stock, valued at approximately $8,623,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. BlackRock Inc. bought a new position in shares of Centene in the second quarter worth $2,660,422,000. AQR Capital Management LLC boosted its stake in Centene by 117.0% in the 4th quarter. AQR Capital Management LLC now owns 31,798,738 shares of the company’s stock worth $1,308,518,000 after purchasing an additional 17,143,904 shares during the period. Wellington Management Group LLP increased its position in shares of Centene by 423.0% during the second quarter. Wellington Management Group LLP now owns 13,301,215 shares of the company’s stock valued at $853,805,000 after buying an additional 10,757,914 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Centene by 5.5% in the fourth quarter. Geode Capital Management LLC now owns 13,271,492 shares of the company’s stock worth $554,338,000 after buying an additional 697,277 shares in the last quarter. Finally, Deerfield Management Company L.P. grew its stake in Centene by 184.0% during the third quarter. Deerfield Management Company L.P. now owns 9,046,000 shares of the company’s stock valued at $322,761,000 after acquiring an additional 5,860,630 shares in the last quarter. Institutional investors own 93.63% of the company’s stock.
Centene Price Performance
CNC opened at $66.92 on Friday. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.15 and a quick ratio of 1.15. The stock’s 50 day simple moving average is $65.56 and its 200 day simple moving average is $54.18. The firm has a market cap of $33.06 billion, a price-to-earnings ratio of -6.41, a PEG ratio of 0.42 and a beta of 1.10. Centene Corporation has a 1 year low of $28.24 and a 1 year high of $69.36.
Analyst Upgrades and Downgrades
CNC has been the topic of several recent analyst reports. Argus upgraded shares of Centene from a “hold” rating to a “buy” rating and set a $80.00 target price on the stock in a research note on Tuesday, August 11th. Zacks Research upgraded Centene from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, July 29th. Sanford C. Bernstein restated an “outperform” rating and issued a $79.00 price objective (up from $68.00) on shares of Centene in a report on Monday, August 3rd. Wells Fargo & Company set a $69.00 price objective on shares of Centene and gave the company an “equal weight” rating in a research note on Monday, July 13th. Finally, Bank of America lifted their target price on shares of Centene from $72.00 to $74.00 and gave the stock a “buy” rating in a research report on Thursday, June 4th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, Centene has an average rating of “Hold” and an average target price of $70.05.
Check Out Our Latest Report on Centene
Insider Buying and Selling
In other Centene news, General Counsel Christopher Koster sold 56,500 shares of the stock in a transaction on Wednesday, August 26th. The shares were sold at an average price of $66.90, for a total transaction of $3,779,850.00. Following the completion of the sale, the general counsel owned 248,854 shares of the company’s stock, valued at $16,648,332.60. This represents a 18.50% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.37% of the stock is owned by corporate insiders.
Centene Profile
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Further Reading
- Five stocks we like better than Centene
- Zscaler’s Strong Quarter Still Left Investors Waiting on 1 Key Signal
- Is Duolingo the Next Netflix-Style Comeback Story?
- GitLab’s AI Tools Are Starting to Turn Developer Demand Into Real Revenue
- GTA VI’s Console Problem Isn’t Take-Two’s Problem
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
